Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory

Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory

To explore trends in blood pressure (BP) control before and during the COVID-19 pandemic. Health systems participating in the National Patient-Centered Clinical Research Network (PCORnet) Blood Pressure Control Laboratory Surveillance System responded to data queries, producing 9 BP control metrics....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mayo Clinic proceedings 2023-05, Vol.98 (5), p.662-675
Hauptverfasser: Chamberlain, Alanna M., Cooper-DeHoff, Rhonda M., Fontil, Valy, Nilles, Ester Kim, Shaw, Kathryn M., Smith, Myra, Lin, Feng, Vittinghoff, Eric, Maeztu, Carlos, Todd, Jonathan V., Carton, Thomas, O’Brien, Emily C., Faulkner Modrow, Madelaine, Wozniak, Gregory, Rakotz, Michael, Sanchez, Eduardo, Smith, Steven M., Polonsky, Tamar S., Ahmad, Faraz S., Liu, Mei, McClay, James C., VanWormer, Jeffrey J., Taylor, Bradley W., Chrischilles, Elizabeth A., Wu, Shenghui, Viera, Anthony J., Ford, Daniel E., Hwang, Wenke, Knowlton, Kirk U., Pletcher, Mark J.
Format: Artikel
Sprache:eng
Schlagworte:
Antihypertensive Agents - pharmacology
Antihypertensive Agents - therapeutic use
Blood Pressure
Care and treatment
COVID-19 - epidemiology
Epidemics
Humans
Hypertension
Hypertension - drug therapy
Hypertension - epidemiology
Influence
Medical care
Original
Pandemics
Risk factors
Statistics
Utilization
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To explore trends in blood pressure (BP) control before and during the COVID-19 pandemic. Health systems participating in the National Patient-Centered Clinical Research Network (PCORnet) Blood Pressure Control Laboratory Surveillance System responded to data queries, producing 9 BP control metrics. Averages of the BP control metrics (weighted by numbers of observations in each health system) were calculated and compared between two 1-year measurement periods (January 1, 2019, through December 31, 2019, and January 1, 2020, through December 31, 2020). Among 1,770,547 hypertensive persons in 2019, BP control to
ISSN:0025-6196
1942-5546
DOI:10.1016/j.mayocp.2022.12.024